GB
Therapeutic Areas
Abyssinia Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ABY-1125 | Alzheimer's Disease | Preclinical |
| ABY-1220 | Alzheimer's Disease | Preclinical |
| Preventative Vaccine | Alzheimer's Disease (Prevention) | Preclinical |
| Oligomer Diagnostic Biomarkers | Alzheimer's Disease Diagnosis | Preclinical/Research |
Leadership Team at Abyssinia Biologics
FG
Frederic Godderis
Co-Founder & Chief Executive Officer
TL
Trebor Lawton
Co-Founder & Chief Technology Officer
EY
Eric Yuen, MD
Chief Medical Officer
EL
Enchi Liu, PhD
Chief Development Officer
DS
Dennis Selkoe, MD
Scientific Advisory Board